| Jun 18 |
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
|
| Jun 17 |
Top Midday Decliners
|
| Jun 17 |
Ovid stock plunges 66% on failed studies for soticlestat
|
| Jun 17 |
Sector Update: Health Care Stocks Decline Premarket Monday
|
| Jun 17 |
Takeda drug for rare types of epilepsy misses goal in late-stage trial
|
| Jun 17 |
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
|
| May 28 |
3 Sorry Penny Stocks to Sell in May While You Still Can
|
| May 14 |
Ovid Therapeutics GAAP EPS of -$0.17
|
| May 14 |
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
|
| May 14 |
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
|
